In addition, varying definitions for positivity of PD‐L1 staining using percentage of PD‐L1–positive tumour cells (TPS—tumour proportion score) or positive tumour and infiltrating immune cells (CPS—combined positive score), different testing platforms and antibodies also make it difficult to compare between various clinical trials.21 The gene discussed is CD274; the disease is neoplasm.